The Revenge Of Obamacare Just Tanked Merck And Other Pharmaceutical Manufacturers
Shares of Merck & Co. Inc. (NYSE:MRK) are currently down $0.58 or 1.55% to $36.92 a share as Obama unveils his latest healthcare initiative.
One damming factor of the President's agenda is a $10B hike in additional fees on drugmakers.
Shares of Glaxo Smith Kline (NYSE:GSK) are also falling, currently down $0.83 or 2.2% to $37.42 a share. AmerisourceBergen Corp. (NYSE:ABC) is down $0.17 or 0.66% to $27.95 a share.
Disclosure: No Positions